MedTrace Logo

A Continuous Glucose Monitor Based Insulin Bolus Calculator

NCT05229445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2022-10-13

No results posted yet for this study

Summary

This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1

Interventions

DEVICE

continuous glucose monitor based insulin bolus calculator

Participants will use the bolus calculator with meals to calculate their insulin bolus doses

Sponsors & Collaborators

  • Welldoc

    lead INDUSTRY

Principal Investigators

  • Grazia Aleppo · Northwestern University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-05
Primary Completion
2022-09-28
Completion
2022-09-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05229445 on ClinicalTrials.gov